IDEAYA Biosciences Shares Rally Premarket After Darovasertib Update >IDYA

News Room
0 Min Read

By Colin Kellaher

Shares of IDEAYA Biosciences Inc. rose sharply in premarket trading on Monday after the precision-medicine oncology company reported a pair of advances for its lead compound darovasertib.

The South San Francisco, Calif., company said its Phase 2 study evaluating the combination of darovasertib and Pfizer Inc.’s cancer drug…

Read the full article here

Share this Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *